KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 170 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $28,520 | -82.7% | 15,933 | -62.4% | 0.00% | -80.0% |
Q1 2023 | $165,041 | -17.1% | 42,427 | -27.5% | 0.01% | 0.0% |
Q4 2022 | $199,016 | +168.9% | 58,534 | +333.9% | 0.01% | +233.3% |
Q3 2022 | $74,000 | +39.6% | 13,491 | +14.4% | 0.00% | +50.0% |
Q2 2022 | $53,000 | -60.7% | 11,793 | -43.8% | 0.00% | -33.3% |
Q4 2021 | $135,000 | +10.7% | 21,000 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $122,000 | -43.8% | 21,000 | 0.0% | 0.00% | -50.0% |
Q2 2021 | $217,000 | -1.8% | 21,000 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $221,000 | -22.5% | 21,000 | +14.1% | 0.01% | -14.3% |
Q4 2020 | $285,000 | +5.9% | 18,400 | 0.0% | 0.01% | -46.2% |
Q3 2020 | $269,000 | -25.3% | 18,400 | -3.3% | 0.01% | -35.0% |
Q2 2020 | $360,000 | +11900.0% | 19,025 | +13686.2% | 0.02% | – |
Q4 2019 | $3,000 | -66.7% | 138 | -90.9% | 0.00% | – |
Q2 2019 | $9,000 | +350.0% | 1,524 | +383.8% | 0.00% | – |
Q1 2019 | $2,000 | -33.3% | 315 | -11.8% | 0.00% | – |
Q4 2018 | $3,000 | -62.5% | 357 | -28.0% | 0.00% | – |
Q3 2018 | $8,000 | +60.0% | 496 | +78.4% | 0.00% | – |
Q2 2018 | $5,000 | -81.5% | 278 | -86.1% | 0.00% | -100.0% |
Q1 2018 | $27,000 | +35.0% | 2,000 | +11.1% | 0.00% | 0.0% |
Q3 2017 | $20,000 | -93.4% | 1,800 | -94.4% | 0.00% | -94.6% |
Q4 2016 | $303,000 | – | 32,196 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |